Delivery Order SPE2DB22D3004-SPE2DB24FPN36
Award Date 3/1/24
Potential Completion Date 3/22/24
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX. The contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX. The $11,642.60 contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order as well as an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $11,642.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,609,986 units of BOTOX 200 unit vials. This delivery order contract has a completion date of March 1, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $11,642.60 firm fixed price delivery order to supply 200 unit vials of BOTOX. This delivery order contract has a performance period through March 12, 2024 and was not set aside for any type of small business. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a $29,106.50 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 200 unit vials of BOTOX. This delivery order falls under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,910.65 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The delivery order is for 200-unit vials of BOTOX. This order is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC does not...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200-unit vials of Botox. The $2,910.65 delivery order has a completion date of March 15, 2024 and was awarded on February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA to deliver...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 unit vials of BOTOX. The $6,985.56 delivery order has an ultimate completion date of April 17, 2024 and was awarded on March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 unit vials of Botox. The $8,731.95 order has a completion date of March 5, 2024 and was issued on February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and the place of performance is Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to...
- The Defense Logistics Agency (DLA) awarded a $1,164.26 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200-unit vials of BOTOX. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPN36Delivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 unit vials of BOTOX. This $29,106.50 contract has a completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This current delivery order is issued under that IDC, which does not have any set-aside designations.
Generated 5/31/24, 10:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.1k | 3/1/24 |